AMBULANTA SPLOŠNE MEDICINE ALENKA SIMONIČ
- Address
- Ulica dr. Hrovata 4, 2270 Ormoz, Slovenia
AMBULANTA SPLOŠNE MEDICINE ALENKA SIMONIČ - Cardiovascular Disease Prevention Center
AMBULANTA SPLOŠNE MEDICINE ALENKA SIMONIČ is a specialized clinical research facility dedicated to cardiovascular disease prevention and management. The center focuses on innovative approaches to treating metabolic risk factors, particularly in patients at high and very high cardiovascular risk, with emphasis on optimizing lipid management strategies through advanced pharmacological interventions.
- Hyperlipidaemia management and LDL-cholesterol reduction strategies
- Cardiovascular disease risk assessment and prevention
- Novel combination therapies including rosuvastatin and ezetimibe treatments
The center's research program emphasizes the evaluation of high-intensity statin therapy and single-pill combination treatments for achieving aggressive LDL-C targets in accordance with contemporary cardiovascular prevention guidelines. Their clinical investigations focus on both efficacy and safety outcomes, particularly targeting patients requiring significant LDL-C reduction of ≥50% from baseline to meet therapeutic goals for high-risk and very-high-risk populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 25 other sites in Slovenia
Therapeutic Area Benchmark — Slovenia
Select a therapeutic area to compare against other sites in Slovenia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovenia
Market Share
Country: Slovenia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AMBULANTA SPLOŠNE MEDICINE ALENKA SIMONIČ
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Rosuvastatin and Rosuvastatin/Ezetimibe Combination in High-Risk Hyperlipidemia Patients: A 12-Week Randomized Trial | KRKA tovarna zdravil d.d. Novo mesto | Phase I | Not Recruiting | Nov 2024 | Jan 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ezetimibe | 1 | Unknown | 2024-11-10 | 2024-11-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.